SCHEMBL4700152

SCHEMBL4700152

CCn1c(C(=C=O)CN(C)C)cnc1C1CC1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PDE1A P54750 1/20 0.33
PDE1B Q01064 1/20 0.33
PDE1C Q14123 1/20 0.33
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4697112 0.76 HTT (0.30)
SCHEMBL1448754 0.75
SCHEMBL4699937 0.75
SCHEMBL1447738 0.75 PDE1C (0.39) PDE1APDE1BPDE1CPOLB
SCHEMBL1447757 0.72 MAPT (0.36) PDE1APDE1BPDE1CPOLB
SCHEMBL4753113 0.68 MAPT (0.34) PDE1APDE1BPDE1CPOLB
SCHEMBL4753112 0.66
SCHEMBL1447711 0.64 PDE1A (0.33) PDE1APDE1BPDE1CPOLB
SCHEMBL4960395 0.62 HCAR1 (0.31)
SCHEMBL19301640 0.60 PDE1A (0.44) PDE1APDE1BPDE1CPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912974-A1 IMIDAZOLYL-PYRIMIDINE COMPOUNDS FOR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS AstraZeneca AB (SE) 2008-04-23 EP disclosed
EP-1828183-A1 4- (4- (IMIDAZOL-4-YL) PYRIMIDIN-2-YLAMINO) BENZAMIDES AS CDK INHIBITORS AstraZeneca AB (SE) 2007-09-05 EP disclosed
WO-2007015064-A1 IMIDAZOLYL-PYRIMIDINE COMPOUNDS FOR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2007-02-08 WO disclosed
WO-2006064251-A1 4- (4- (IMIDAZOL-4-YL) PYRIMIDIN-2-YLAMINO) BENZAMIDES AS CDK INHIBITORS ASTRAZENECA AB (SE) 2006-06-22 WO disclosed